Literature DB >> 12692192

Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users.

Santhi Ganesan1, Joseph Felo, Mario Saldana, Victor F Kalasinsky, Michael R Lewin-Smith, Joseph F Tomashefski.   

Abstract

Crospovidone is an insoluble polymer of N-vinyl-2-pyrrolidone that is used as a disintegrant in pharmaceutical tablets. It can potentially embolize to the lung when aqueous tablet suspensions are injected intravenously. In this report, we identified embolized crospovidone in autopsy-derived lung tissue from three adult IV drug users, 1 man and 2 women, whose ages respectively were 27, 38, and 40 years. Suspected crospovidone was compared with pharmaceutical-grade crospovidone by means of histochemical stains, transmission electron microscopy, and infrared spectroscopy. Similar particles were also observed by light microscopy in a 4-mg tablet of hydromorphone, a preparation prescribed to two of the patients. Two patients had sickle cell disease and were taking methadone and/or hydromorphone for pain management; the third was receiving parenteral hyperalimentation after small bowel resection. Crospovidone appeared as deeply basophilic, coral-like particles within pulmonary arteries and in extravascular foreign-body granulomas. Intrapulmonary crospovidone stained similarly to the pure substance, including intense staining with mucicarmine, Congo red, and Masson trichrome. With Movat pentachrome stain, both intravascular and purified crospovidone appeared orange-yellow, whereas most interstitial particles associated with giant cells stained blue-green. Alcian blue failed to stain intravascular or purified crospovidone but strongly decorated some phagocytized particles. Ultrastructurally, both purified powder and tissue deposits of crospovidone appeared as irregular, electron dense, laminated, and finely granular material. Intrapulmonary crospovidone was associated with inflammatory cells and exhibited degenerative changes. By infrared spectroscopy, crospovidone in tissue had the same spectral characteristics as pharmaceutical grade crospovidone and the library reference, polyvinylpyrrolidone (PVP). We conclude that crospovidone contributes to pulmonary vascular injury in some persons who illicitly inject pharmaceutical tablets. It is readily identifiable histologically and distinguishable from other tablet constituents, such as cornstarch, talc, and microcrystalline cellulose. The variable staining with Alcian blue and Movat suggests that crospovidone is altered in vivo by the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692192     DOI: 10.1097/01.MP.0000062653.65441.DA

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

1.  Fatal foreign-body granulomatous pulmonary embolization due to microcrystalline cellulose in a patient receiving total parenteral nutrition: all crystals are not what they seem.

Authors:  Sarah Strickland; Elena Pena; Alfredo E Walker
Journal:  Forensic Sci Med Pathol       Date:  2015-03-04       Impact factor: 2.007

Review 2.  Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition.

Authors:  Mallesh Kurakula; G S N Koteswara Rao
Journal:  J Drug Deliv Sci Technol       Date:  2020-09-02       Impact factor: 3.981

3.  Systemic AA Amyloidosis Associated With Intravenous Injection of Oral Prescription Opioids-An Autopsy Case Report.

Authors:  Kenneth M Zabel; Grace Y Lin; Rebecca E Sell; Omonigho Aisagbonhi
Journal:  Am J Forensic Med Pathol       Date:  2021-09-10       Impact factor: 1.108

4.  Risk Factors for Hemorrhagic Complications following Pipeline Embolization Device Treatment of Intracranial Aneurysms: Results from the International Retrospective Study of the Pipeline Embolization Device.

Authors:  W Brinjikji; G Lanzino; H J Cloft; A H Siddiqui; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

5.  Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy.

Authors:  Michele L Pearson; Joseph V Selby; Kenneth A Katz; Virginia Cantrell; Christopher R Braden; Monica E Parise; Christopher D Paddock; Michael R Lewin-Smith; Victor F Kalasinsky; Felicia C Goldstein; Allen W Hightower; Arthur Papier; Brian Lewis; Sarita Motipara; Mark L Eberhard
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

6.  Intravascular Talcosis due to Intravenous Drug Use Is an Underrecognized Cause of Pulmonary Hypertension.

Authors:  Christopher C Griffith; Jay S Raval; Larry Nichols
Journal:  Pulm Med       Date:  2012-05-07

7.  Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome.

Authors:  Ida Viken Stalund; Gro Nygard Riise; Friedemann Leh; Tormod Karlsen Bjånes; Lars Riise; Einar Svarstad; Sabine Leh
Journal:  F1000Res       Date:  2021-04-19

8.  An Unusual and Fatal Cause of Miliary Nodules on Chest Radiography.

Authors:  Anmol Cheema; Saira Chaughtai; Usman Mazahir; Manimala Roy; Mohammad A Hossain
Journal:  J Clin Med       Date:  2018-06-29       Impact factor: 4.241

9.  Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California.

Authors:  Hayley J Koslik; Jisha Joshua; Jazmine Cuevas-Mota; Daniel Goba; Eyal Oren; John E Alcaraz; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2020-07-02       Impact factor: 4.492

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.